The effect of angiotensin-converting enzyme genotype on acute mountain sickness and summit success in trekkers attempting the summit of Mt. Kilimanjaro (5,895 m)

European Journal of Applied Physiology

Volumn 105, Issue 3, 2009, Pages 373-379

  Kalson, Nicholas S ^a   Thompson, Julian ^b   Davies, Andrew J ^a   Stokes, Suzy ^a   Earl, Mark D ^a   Whitehead, Adam ^a   Tyrrell Marsh, Ian ^a   Frost, Hannah ^a   Montgomery, Hugh ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Acclimatisation; Altitude; Angiotensin converting enzyme; Genetics; Hypoxia

Indexed keywords

ACETAZOLAMIDE; DIPEPTIDYL CARBOXYPEPTIDASE;

ALLELE; ALTITUDE ACCLIMATIZATION; ALTITUDE DISEASE; ARTICLE; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HYPOXIA; MAJOR CLINICAL STUDY; MALE; MOUNTAINEERING; PRIORITY JOURNAL; SCORING SYSTEM; TANZANIA;

ACCLIMATIZATION; ACUTE DISEASE; ADULT; ALLELES; ALTITUDE SICKNESS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MOUNTAINEERING; PEPTIDYL-DIPEPTIDASE A; RISK FACTORS; TANZANIA; TIME AND MOTION STUDIES;

EID: 59249094064     PISSN: 14396319     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00421-008-0913-5     Document Type: Article

References (27)

1. Bartsch P, Shaw S, Franciolli M et al (1988) Atrial natriuretic peptide in acute mountain sickness. J Appl Physiol 65:1929-1937
2. Bartsch P, Pfluger N, Audetat M et al (1991) Effects of slow ascent to 4559 M on fluid homeostasis. Aviat Space Environ Med 62:105-110
3. Basnyat B, Murdoch DR (2003) High-altitude illness. Lancet 361:1967-1974
4. Bigham AW, Kiyamu M, Leon-Velarde F et al (2008) Angiotensin-converting enzyme genotype and arterial oxygen saturation at high altitude in Peruvian Quechua. High Alt Med Biol 9:167-178
5. Costerousse O, Danilov S, henc-Gelas F (1997) Genetics of angiotensin I-converting enzyme. Clin Exp Hypertens 19:659-669
6. Danser AH, Schalekamp MA, Bax WA et al (1995) Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 92:1387-1388
7. Dehnert C, Weymann J, Montgomery HE et al (2002) No association between high-altitude tolerance and the ACE I/D gene polymorphism. Med Sci Sports Exerc 34:1928-1933
8. Hackett PH, Roach RC (2001) High-altitude illness. N Engl J Med 345:107-114
9. Hackett PH, Rennie D, Hofmeister SE et al (1982) Fluid retention and relative hypoventilation in acute mountain sickness. Respiration 43:321-329
10. Koehle MS, Wang P, Guenette JA et al (2006) No association between variants in the ACE and angiotensin II receptor 1 genes and acute mountain sickness in Nepalese pilgrims to the Janai Purnima Festival at 4380 m. High Alt Med Biol 7:281-289
11. Maggiorini M, Muller A, Hofstetter D et al (1998) Assessment of acute mountain sickness by different score protocols in the Swiss Alps. Aviat Space Environ Med 69:1186-1192
12. Milledge JS, Beeley JM, McArthur S et al (1989) Atrial natriuretic peptide, altitude and acute mountain sickness. Clin Sci (Lond) 77:509-514
13. Montgomery HE, Marshall R, Hemingway H et al (1998) Human gene for physical performance. Nature 393:221-222
14. Myerson S, Hemingway H, Budget R et al (1999) Human angiotensin I-converting enzyme gene and endurance performance. J Appl Physiol 87:1313-1316
15. Patel S, Woods DR, Macleod NJ et al (2003) Angiotensin-converting enzyme genotype and the ventilatory response to exertional hypoxia. Eur Respir J 22:755-760
16. Paul M, Poyan MA, Kreutz R (2006) Physiology of local renin-angiotensin systems. Physiol Rev 86:747-803
17. Payne J, Montgomery H (2003) The renin-angiotensin system and physical performance. Biochem Soc Trans 31:1286-1289
18. Rigat B, Hubert C, henc-Gelas F et al (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346
19. Roach R, Bartsch P, Hackett PH (1993) The Lake Louise AMS Scoring Consensus Committee. The Lake Louise acute mountain sickness scoring system. In: Sutton JR et al (eds) Hypoxia and molecular medicine. Queen City Printers, Burlington
20. Rupert JL, Koehle MS (2006) Evidence for a genetic basis for altitude-related illness. High Alt Med Biol 7:150-167
21. Schneider M, Bernasch D, Weymann J et al (2002) Acute mountain sickness: influence of susceptibility, preexposure, and ascent rate. Med Sci Sports Exerc 34:1886-1891
22. Thompson J, Raitt J, Hutchings L et al (2007) Angiotensin-converting enzyme genotype and successful ascent to extreme high altitude. High Alt Med Biol 8:278-285
23. Tsianos G, Eleftheriou KI, Hawe E et al (2005) Performance at altitude and angiotensin I-converting enzyme genotype. Eur J Appl Physiol 93:630-633
24. Ward MP, Milledge JS, West JB (2000) High altitude medicine and physiology. Oxford University Press, New York
25. Woods DR, Montgomery HE (2001) Angiotensin-converting enzyme and genetics at high altitude. High Alt Med Biol 2:201-210
26. Woods DR, Pollard AJ, Collier DJ et al (2002) Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene and arterial oxygen saturation at high altitude. Am J Respir Crit Care Med 166:362-366
27. Zhang B, Tanaka H, Shono N et al (2003) The I allele of the angiotensin-converting enzyme gene is associated with an increased percentage of slow-twitch type I fibers in human skeletal muscle. Clin Genet 63:139-144